LungLife AI, Inc. (GB:LLAI) has released an update.
LungLife AI, Inc., a company specializing in diagnostic solutions for lung cancer, announced a successful Annual General Meeting where all proposed resolutions were approved by its members. The firm emphasizes the significance of its minimally invasive LungLB test in the early detection of lung cancer, aiming to reverse the current early detection rate from 20% to 80% in the future.
For further insights into GB:LLAI stock, check out TipRanks’ Stock Analysis page.
